Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review

被引：17
作者：
Franchini, Massimo [1 ]
Capuzzo, Enrico [1 ]
Liumbruno, Giancarlo M. [2 ]
机构：
[1] Carlo Poma Hosp, Dept Haematol & Transfus Med, Mantua, Italy
[2] Italian Natl Blood Ctr, Natl Inst Hlth, Rome, Italy
来源：
BLOOD TRANSFUSION | 2016年 / 14卷 / 05期
关键词：
lipoprotein apheresis; lipoprotein(a); thrombosis; TRANSFER PROTEIN INHIBITOR; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; LIPID APHERESIS; DOUBLE-BLIND; RISK-FACTOR; LDL-C; SAFETY; EFFICACY;
D O I：
10.2450/2015.0163-15
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lipoprotein(a), which consists of a low-density lipoprotein (LDL) particle linked to an apolipoprotein(a) moiety, is currently considered an independent risk factor for cardiovascular disease due to its atherogenic (LDL-like) and prothrombotic (plasminogen-like) properties. The aim of this review is to provide an overview of the current and newer therapies for lowering increased lipoprotein(a) levels, focusing on lipoprotein apheresis. After a systematic literature search, we identified ten studies which, overall, documented that lipoprotein apheresis is effective in reducing increased lipoprotein(a) levels and cardiovascular events.
引用
收藏
页码：413 / 418
页数：6
相关论文
共 50 条
  • [31] Familial hypercholesterolemia: Current treatment options and patient selection for low-density lipoprotein apheresis
    Hemphill, Linda C.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 346 - 349
  • [32] Fatty acid analysis in serum of patients with elevated lipoprotein(a) and cardiovascular disease undergoing lipoprotein apheresis
    Mickiewicz, Agnieszka
    Marlega-Linert, Joanna
    Czapiewska, Monika
    Marcinkowska, Marta
    Krzesinska, Aleksandra
    Kuchta, Agnieszka
    Fijalkowski, Marcin
    Gruchala, Marcin
    Mika, Adriana
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (02) : e197 - e206
  • [33] Systematic Review of Low-Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
    Wang, Anthony
    Richhariya, Akshara
    Gandra, Shravanthi R.
    Calimlim, Brian
    Kim, Lisa
    Quek, Ruben G. W.
    Nordyke, Robert J.
    Toth, Peter P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (07):
  • [34] Lipoprotein (a) as a treatment target for cardiovascular disease prevention and related therapeutic strategies: a critical overview
    Parthymos, Ioannis
    Kostapanos, Michael S.
    Mikhailidis, Dimitri P.
    Florentin, Matilda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : 739 - 755
  • [35] Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review
    Luirink, Ilse K.
    Determeijer, Jim
    Hutten, Barbara A.
    Wiegman, Albert
    Bruckert, Eric
    Schmitt, Claus P.
    Groothoff, Jaap W.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (01) : 31 - 39
  • [36] Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature
    Sheashaa, Hesham
    Mousa, Hana
    Abbas, Mohammed Tiseer
    Farina, Juan M.
    Awad, Kamal
    Pereyra, Milagros
    Scalia, Isabel G.
    Ali, Nima Baba
    Javadi, Niloofar
    Bismee, Nadera N.
    Esfahani, Sogol Attaripour
    Ibrahim, Omar
    Abdelfattah, Fatmaelzahraa
    Ibrahim, Ramzi
    Abdelnabi, Mahmoud
    Ayoub, Chadi
    Arsanjani, Reza
    BIOMOLECULES, 2025, 15 (02)
  • [37] Lipoprotein apheresis reduces adipocyte fatty acid-binding protein serum levels
    Lamounier-Zepter, V.
    Look, C.
    Ehrhart-Bornstein, M.
    Bornstein, S. R.
    Fischer, S.
    Julius, U.
    ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (01) : 129 - 134
  • [38] Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease
    Ma, Louis
    Waldmann, Elisa
    Ooi, Esther M. M.
    Chan, Dick C.
    Barrett, Hugh P. R.
    Watts, Gerald F.
    Parhofer, Klaus G.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (02)
  • [39] Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis
    de Boer, Lotte M.
    Oorthuys, Anna O. J.
    Wiegman, Albert
    Langendam, Miranda W.
    Kroon, Jeffrey
    Spijker, Rene
    Zwinderman, Aeilko H.
    Hutten, Barbara A.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (05) : 779 - 792
  • [40] Lipoprotein apheresis reduces circulating galectin-3 in humans
    Eliaz, Isaac
    Weil, Elaine
    Dutton, Julie-Ann
    McCalley, Audrey E.
    Nolte, Barbie
    Moriarty, Patrick M.
    JOURNAL OF CLINICAL APHERESIS, 2016, 31 (04) : 388 - 392
12345